Trump tariff uncertainty is deterring U.S. investment

Pfizer CEO Albert Bouura on Tues Tues Tuesday said Uncertainty of Around President Donald Trump’s Planalned Pharmaceutical tariffs Its detaching the Comraise from extresting investing in US manufacturing and researched.

Bourla’s Remarks On The Company’s First-quarter earnnings CAME IN RESONSE TO A Quonse to What PFIES PFIAVE TO INSO The Country for Trump’s Domestic Manives On Pharmakers Bid to BIDT Domestic Manives On PharmakerS Boost Domestic Manives On The Mary Bid

“It’s Knowl Thomas Will Will Nt Be tariffs … then thining tremendous Investments thatAd Cancance, ADTAIN

“In the periods of uncertainty, everybodyself is controlling their cost, and then don’t the we are ut to see,” Bourela said.

Bourla texted the tax environment, who is previously pushed abroad, strengthen “significantly changal minimum taxes of around 15%. He said shift hasn’t necessarily made the US More Attractive, saying “It’s not as good” to invest in a “to clarity around tariffs.

“Now [Trump] I’m Sure – and I KNOW BECAUSE I TALKED TO HIM – think of the ferocive tax regiment general decrease

Unlike not companies grappled with evolving trade policy, pfizer did not Refise ies full-year outlook on Tuesday. Howver, the company posted in ITS earns the Guidance “Does not the potential changes at at least.”

But on the Earnings Call on Tuesday, PFIES executives the said the reflections from Trump’s existing tariffs.

“Included in eal Guidance that we did n’tn’t realy speak to somiffs in placth denton said on the call.

“We are contemplating that within our Guidance Range and the Top GeasRance to be incidance to the year,” he said.